Access Scientific Inc. closed a $2 million equity-based financing round.
San Diego-based company has begun the roll out of its new catheter introducer product.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Access Scientific Inc. closed a $2 million equity-based financing round.
San Diego-based company has begun the roll out of its new catheter introducer product.
Patient Safety Technologies’ Q3 sales soar as its swings to black
Patient Safety Technologies, Inc. (OTC:PSTX) posted profits of $977,000, or 4 cents per diluted share, on revenue of $4.1 million during the three months ended Sept. 30. That compares with losses of $978,000, or 17 cents per diluted share, on revenues of $3.3 million during the same period last year.
One of the biggest draws of medical device sales is feeling that you are contributing to the health and well-being of others through the products you represent. This is an important motivation for most people I interview who want to break into the industry, as well as one of the main reasons that people who are already part of the industry find it so rewarding.
Many trauma reps in particular derive a incredible satisfaction from providing the right products to assist a surgeon in putting someone back together after an accident. They love the immediacy and high stakes of getting everything right in order to achieve the best outcome for patients.
SuccessEHS gives doctors access to medical records via smartphones: Birmingham, Ala.-based electronic health record developer SuccessEHS launched an Apple Inc. (NSDQ:AAPL) iPhone app that gives healthcare providers access to the company’s EHR system.
Pharmaceutical companies landed a big win in Vermont yesterday, after a three-judge panel for the U.S. Court of Appeals for the 2nd Circuit ruled that a Vermont law restricting the mining drug prescription data violates the First Amendment.
Three companies that mine information on the prescription patterns of physicians and sell the data to pharmaceutical companies sued the Green Mountain State over the law, which bans the use of prescriber-identifiable data for drug marketing unless the prescribing caregiver consents.
LifeImage Inc. won a two-year federally-funded medical image-sharing contract.
The Newton, Mass.-based healthcare IT firm was selected by the Radiological Society of North America to serve as a digital "clearinghouse" for an imaging project funded by the National Institute of Health.
Hologic Inc.’s (NSDQ:HOLX) long wait to launch its 3D breast exam system is close to over.
The company received an "approvable letter" from the Food & Drug Administration for its Selenia Dimensions 3-D digital mammography tomosynthesis system. The letter indicates that the final approval of the device maker’s pre-market approval application for the breast exam tool is only subject to a "satisfactory review and inspection of [the company’s] manufacturing facility, methods and controls," Hologic said.
A small Columbus, Ohio, company is hoping to develop a blood glucose monitor for diabetics who are sick of pricking their skin to check their sugar levels.
Advanced Bionics recalled its cochlear hearing-aid implants.
The subsidiary of Staefa, Switzerland-based Sonova Holding AG (SIX:SOON) received reports that is HiRes 90K cochlear implant device had malfunctioned eight to 10 days after it was activated. Two patients suffered from pain and loud noise, according to the company.
Advanced Bionics notified the Food & Drug Administration of the problem and its working with the agency to rectify it.
Former national security advisor Gen. James Jones joined the board of Invacare Corp. (NYSE:IVC), replacing departing Ohio governor-elect John Kasich effective Dec. 1.
Health insurer warns diabetes will cost $3.4 trillion over the next decade. Costs related to diabetes will run up a tab of almost $3.4 trillion through 2020 in the United States, with more than 60 percent paid for by the U.S. government — unless people lose weight, a study released today by health insurer UnitedHealth Group Inc. revealed, according to Bloomberg.